Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lyra Therapeutics (LYRA) Return on Assets (2021 - 2025)

Lyra Therapeutics has reported Return on Assets over the past 5 years, most recently at 0.72% for Q4 2025.

  • Quarterly results put Return on Assets at 0.72% for Q4 2025, up 56.0% from a year ago — trailing twelve months through Dec 2025 was 0.72% (up 56.0% YoY), and the annual figure for FY2025 was 0.56%, up 33.0%.
  • Return on Assets for Q4 2025 was 0.72% at Lyra Therapeutics, down from 0.68% in the prior quarter.
  • Over the last five years, Return on Assets for LYRA hit a ceiling of 0.44% in Q3 2022 and a floor of 1.3% in Q1 2025.
  • Median Return on Assets over the past 5 years was 0.68% (2025), compared with a mean of 0.73%.
  • Biggest five-year swings in Return on Assets: crashed -81bps in 2024 and later soared 56bps in 2025.
  • Lyra Therapeutics' Return on Assets stood at 0.71% in 2021, then surged by 32bps to 0.48% in 2022, then grew by 1bps to 0.48% in 2023, then crashed by -170bps to 1.29% in 2024, then skyrocketed by 44bps to 0.72% in 2025.
  • The last three reported values for Return on Assets were 0.72% (Q4 2025), 0.68% (Q3 2025), and 0.71% (Q2 2025) per Business Quant data.